Medicine News and Research

RSS

FDA approves Xiaflex drug for treatment of Dupuytren's contracture

The U.S. Food and Drug Administration (FDA) has approved Xiaflex, a new drug to treat Dupuytren's contracture (or disease) that was discovered and developed by Marie A. Badalamente, Ph.D., and Lawrence C. Hurst, M.D., in the Department of Orthopaedics at Stony Brook University Medical Center.

4 Feb 2010

Acupuncture viable for treatment of depression during pregnancy

In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, in Chicago, researchers will unveil findings that show that acupuncture may be an effective treatment for depression during pregnancy.

4 Feb 2010

DNA variants in mother and fetus can increase risk of preterm labor

Researchers at the National Institutes of Health have identified DNA variants in mothers and fetuses that appear to increase the risk for preterm labor and delivery.

4 Feb 2010

HUCB-derived purified and expanded CD133+ cells may show promise in cellular cardiomyoplasty

Researchers at the Pontif-cia Universidade Cat-lica do Paran- and Instituto Carlos Chagas have evaluated the therapeutic potential of purified and expanded CD133+ cells human umbilical cord blood (HUCB)-derived in treating myocardial infarction by intramyocardially injecting them into a rat model. Patients who have high cardiovascular risks have fewer endothelial progenitor cells (EPCs) and their EPCs exhibit greater in vitro senescence.

4 Feb 2010

Study could lead to non-surgical alternatives for tonsillectomies

Children with obstructive sleep apnea (OSA) may one day be able to have an injection or use a throat spray instead of getting their tonsils removed to cure their snoring, according to a new study from the University of Chicago, which found that a specific gene product may be responsible for the proliferation of adenotonsillar tissue that can cause pediatric OSA.

4 Feb 2010

Canadian Institutes of Health Research awards $2.3M for study on integrative biology of inflammatory diseases

A research team led by Dr. John D. Rioux, a researcher at the Montreal Heart Institute (MHI) and professor in the faculty of medicine at the Université de Montréal, has been awarded a grant of more than $2.3 million to finance a major research project on the integrative biology of inflammatory diseases. From among the roughly 70 applications submitted, Dr. Rioux's team is one of six selected by the Canadian Institutes of Health Research to receive the Emerging Team Grant - From Genes to Proteins, Cells, Tissues and Patients.

4 Feb 2010

Geisinger Health System and TGen sign research agreement

Geisinger Health System and the Translational Genomics Research Institute today announced the signing of a strategic research agreement that provides a focused look at the gaps in clinical medicine where biomedical research can make a difference.

4 Feb 2010

Despite improvements, aid delivery bottlenecks persist in Haiti

Three weeks after a major earthquake struck Haiti, challenges in getting aid to those in need persist, the Washington Post reports. "Rajiv Shah, the administrator of the U.S. Agency for International Development, said the relief effort has escalated in recent days and will continue to do so.

4 Feb 2010

MedQuist to acquire Spheris' domestic business

MedQuist Inc., a leading provider of medical transcription software and services, today announced that it has agreed to purchase the domestic business of Spheris Inc., a global provider of clinical documentation technology and services that recently filed for Chapter 11 bankruptcy protection.

4 Feb 2010

Recent clinical trials in patients with ALBP show that SOMA 250 mg reduces disability

A recent analysis of two pivotal clinical trials in patients with acute low back pain (ALBP) who were treated with SOMA® (carisoprodol) 250 mg showed significantly improved functionality and reduced disability after three days of treatment, as measured by the Roland-Morris Disability Questionnaire (RMDQ).

4 Feb 2010

EPMA Journal promotes new philosophy in patient treatment

Springer and the European Association for Predictive, Preventive and Personalised Medicine have founded, as the Association's official publication, the EPMA Journal.

4 Feb 2010

New vaccine to prevent malaria infection shown promise to protect young children

A new vaccine to prevent the deadly malaria infection has shown promise to protect the most vulnerable patients - young children - against the disease, according to an international team of researchers led by the University of Maryland School of Medicine's Center for Vaccine Development (CVD) and the Malaria Research and Training Center at the University of Bamako in Mali, West Africa.

4 Feb 2010

TGen, Geisinger Health System sign strategic research agreement

The Translational Genomics Research Institute (TGen) and Geisinger Health System today announced the signing of a strategic research agreement that provides for a focused look at the gaps in clinical medicine where biomedical research can make a difference.

4 Feb 2010

Validation results of SmartChip Real-Time PCR System to be presented at CHI's conference

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genetic analysis systems, today announced that WaferGen scientists will present validation results of the company's SmartChip™ Real-Time PCR System at Cambridge Healthcare Institute's 17th International Molecular Medicine Tri-Conference.

3 Feb 2010

Researchers discover anomalies that cause lack of motivation in ADHD children

Until now, attention-deficit/hyperactivity disorder (ADHD) was related to alterations in the brain affecting attention and cognitive processes. Researchers at Universitat Aut-noma de Barcelona and the Vall d'Hebron University Hospital for the first time have discovered anomalies in the brain's reward system related to the neural circuits of motivation and gratification.

3 Feb 2010

Major study of perfusion imaging under way to assess value of alternative diagnostic methods

Cardiologists and heart imaging specialists at 15 medical centers in eight countries, and led by researchers at Johns Hopkins, have enrolled the first dozen patients in a year-long investigation to learn whether the subtle squeezing of blood flow through the inner layers of the heart is better than traditional SPECT nuclear imaging tests and other diagnostic radiology procedures for accurately tracking the earliest signs of coronary artery clogs.

3 Feb 2010

Study shows Cymbalta reduces chronic low back pain

In a new study, 60 mg of Cymbalta® (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain rating, compared with placebo.

3 Feb 2010

FDA approves Labopharm's OLEPTRO antidepressant for MDD

Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.

3 Feb 2010

Daiichi Sankyo initiates Phase III trial of edoxaban in reducing recurrent VTE complications

Daiichi Sankyo Company, Limited, announced today that it has initiated a new large-scale pivotal Phase III trial for edoxaban, its investigational oral Factor Xa inhibitor. This new study, called HOKUSAI (pronounced hoe·koo·sigh) VTE, is evaluating the safety and efficacy of edoxaban in reducing recurrent venous thromboembolic (VTE) complications in patients with deep vein thrombosis (DVT) and/or pulmonary embolism (PE).

3 Feb 2010

New study compares two treatment options for clubfoot - Ponseti method and surgical treatment

Clubfoot affects one in a thousand babies born in the United States, but with proper corrective treatment and follow-up, infants born with clubfoot can have feet compatible with an active, normal lifestyle.

3 Feb 2010

Medicine News and Research

FDA approves Xiaflex drug for treatment of Dupuytren's contracture

Acupuncture viable for treatment of depression during pregnancy

DNA variants in mother and fetus can increase risk of preterm labor

HUCB-derived purified and expanded CD133+ cells may show promise in cellular cardiomyoplasty

Study could lead to non-surgical alternatives for tonsillectomies

Canadian Institutes of Health Research awards $2.3M for study on integrative biology of inflammatory diseases

Geisinger Health System and TGen sign research agreement

Despite improvements, aid delivery bottlenecks persist in Haiti

MedQuist to acquire Spheris' domestic business

Recent clinical trials in patients with ALBP show that SOMA 250 mg reduces disability

EPMA Journal promotes new philosophy in patient treatment

New vaccine to prevent malaria infection shown promise to protect young children

TGen, Geisinger Health System sign strategic research agreement

Validation results of SmartChip Real-Time PCR System to be presented at CHI's conference

Researchers discover anomalies that cause lack of motivation in ADHD children

Major study of perfusion imaging under way to assess value of alternative diagnostic methods

Study shows Cymbalta reduces chronic low back pain

FDA approves Labopharm's OLEPTRO antidepressant for MDD

Daiichi Sankyo initiates Phase III trial of edoxaban in reducing recurrent VTE complications

New study compares two treatment options for clubfoot - Ponseti method and surgical treatment

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News